Literature DB >> 5182173

Cloxacillin in treatment of acute osteomyelitis.

J H Green.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5182173      PMCID: PMC1845084          DOI: 10.1136/bmj.2.5549.414

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  SOME ASPECTS OF ACUTE HAEMATOGENOUS OSTEITIS IN CHILDREN.

Authors:  T S MANN
Journal:  Br Med J       Date:  1963-12-21

2.  TREATMENT OF ACUTE HAEMATOGENOUS OSTEITIS IN CHILDREN ASSESSED IN A CONSECUTIVE SERIES OF SELECTED CASES.

Authors:  G A NELIGAN; F M ELDERKIN
Journal:  Br Med J       Date:  1965-05-22

3.  Acute hematogenous osteomyelitis. A review of sixty-six cases.

Authors:  J L WINTERS; I CAHEN
Journal:  J Bone Joint Surg Am       Date:  1960-06       Impact factor: 5.284

4.  Late results in the treatment of one hundred cases of acute haematogenous osteomyelitis.

Authors:  J TRUETA; J D MORGAN
Journal:  Br J Surg       Date:  1954-03       Impact factor: 6.939

5.  The penicillin treatment of acute haematogenous osteitis: a review of some unsatisfactory results.

Authors:  W M DENNISON
Journal:  Glasgow Med J       Date:  1952-01
  5 in total
  4 in total

1.  The use of antibiotic therapy as an adjunct in treatment of bone and joint infections.

Authors: 
Journal:  Can J Infect Dis       Date:  1994-01

2.  Choice of antibiotics in management of acute osteomyelitis and acute septic arthritis in children.

Authors:  S Nade
Journal:  Arch Dis Child       Date:  1977-09       Impact factor: 3.791

3.  Acute haematogenous osteitis.

Authors:  J R Anderson; J D Orr; D A Maclean; W G Scobie
Journal:  Arch Dis Child       Date:  1980-12       Impact factor: 3.791

Review 4.  Shorter courses of parenteral antibiotic therapy do not appear to influence response rates for children with acute hematogenous osteomyelitis: a systematic review.

Authors:  Nicole Le Saux; Andrew Howard; Nicholas J Barrowman; Isabelle Gaboury; Margaret Sampson; David Moher
Journal:  BMC Infect Dis       Date:  2002-08-14       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.